<p>Mice were infected with 4–20 i.n. ECTV LD<sub>50</sub>. (A, B) CPGs treatments with or without VACV-Lister on day 2 (A) and 3 (B) p.e. (C) Poly(I:C) treatments with or without VACV-Lister or VACV-Lister alone on day 2 p.e. (D) Poly(I:C) treatments with or without VACV-Lister or MVA and only vaccines treatments on day 3 p.e. (E, F) Poly(I:C) treatments with or without VACV-Lister or MVA and only MVA on day 4 (E) and 5 (F) p.e. Asterisk denote for significant difference in the area-under-the curve of weight changes along the entire experiment of the treated groups vs. the infected untreated group (* P<0.05, ** P<0.01, *** P<0.001, **** P<0.0001, <i>t</i>-test). Data collection for each treatment (weight change (mean, SE)) is indicated. Mor...
<p>(A) Body weight change and (B) clinical score of mice infected with 10<sup>6</sup> TCID<sub>50</s...
<p>(A) Change of mice body weight after injecting the AdEasy or AdEasy-HMGA-6 virus into the liver. ...
<p>The percentage (A) and degree (B) of morbidity of Balb/c mice immunized with pE1D2, pE2D2 and con...
<p>Mice were inoculated with 100 PFU of the indicated viruses and (A, B) weight loss measured on a d...
<p>Viral loads were determined by plaque assay from BALB/c mice 8 days postexposure (p.e.) following...
<p>(A) Groups of female C57/BL6 mice (n = 5–8) were infected with 10<sup>5</sup>, 10<sup>6</sup> and...
<p>*Mice were inoculated with the specified dose via intracerebral inoculation in a volume of 30 ul....
<p>Mice were ip. infected with 10<sup>7</sup> or 10<sup>6</sup> (A), or with 10<sup>5</sup> to 10<su...
<p>A) Weight changes of mice; B) Mortality of mice; C) Virus titers of the mouse lungs and brains: f...
<p>Three groups of mice, ICOS-WT, KO, and YF were intranasally infected with 1000 IFUs of <i>Chlamyd...
<p>Following RU486 treatment, mice (n = 11/group) were infected i.n. with 10<sup>4</sup> PFU of V<su...
<p>(A) Weight loss. Groups of 5 to 10 four-week-old C57BL/6 mice were infected intranasally with 10<...
<p>A/J mice infected with the indicated viruses were monitored for loss of body weight and mortaliti...
<p>Survival rates (A) and bodyweight changes (B) after challenge with the viruses. BALB/c mice were ...
<p>(A) Pre challenge percent change in weight in mock vs vaccinated animals. Percentages normalized ...
<p>(A) Body weight change and (B) clinical score of mice infected with 10<sup>6</sup> TCID<sub>50</s...
<p>(A) Change of mice body weight after injecting the AdEasy or AdEasy-HMGA-6 virus into the liver. ...
<p>The percentage (A) and degree (B) of morbidity of Balb/c mice immunized with pE1D2, pE2D2 and con...
<p>Mice were inoculated with 100 PFU of the indicated viruses and (A, B) weight loss measured on a d...
<p>Viral loads were determined by plaque assay from BALB/c mice 8 days postexposure (p.e.) following...
<p>(A) Groups of female C57/BL6 mice (n = 5–8) were infected with 10<sup>5</sup>, 10<sup>6</sup> and...
<p>*Mice were inoculated with the specified dose via intracerebral inoculation in a volume of 30 ul....
<p>Mice were ip. infected with 10<sup>7</sup> or 10<sup>6</sup> (A), or with 10<sup>5</sup> to 10<su...
<p>A) Weight changes of mice; B) Mortality of mice; C) Virus titers of the mouse lungs and brains: f...
<p>Three groups of mice, ICOS-WT, KO, and YF were intranasally infected with 1000 IFUs of <i>Chlamyd...
<p>Following RU486 treatment, mice (n = 11/group) were infected i.n. with 10<sup>4</sup> PFU of V<su...
<p>(A) Weight loss. Groups of 5 to 10 four-week-old C57BL/6 mice were infected intranasally with 10<...
<p>A/J mice infected with the indicated viruses were monitored for loss of body weight and mortaliti...
<p>Survival rates (A) and bodyweight changes (B) after challenge with the viruses. BALB/c mice were ...
<p>(A) Pre challenge percent change in weight in mock vs vaccinated animals. Percentages normalized ...
<p>(A) Body weight change and (B) clinical score of mice infected with 10<sup>6</sup> TCID<sub>50</s...
<p>(A) Change of mice body weight after injecting the AdEasy or AdEasy-HMGA-6 virus into the liver. ...
<p>The percentage (A) and degree (B) of morbidity of Balb/c mice immunized with pE1D2, pE2D2 and con...